<ѻýҕl>FDA Broadens Options for Relapsed/Refractory Multiple Myeloma With Teclistamabѻýҕl> Bispecific antibody achieved durable responses in a majority of heavily pretreated patients Oct 25, 2022
<ѻýҕl>Sexual Health Not Part of Discussion for Women Undergoing Brachytherapyѻýҕl> Much less likely than men to be queried about sexual function when receiving treatment Oct 25, 2022
<ѻýҕl>Shorter Course of Radiation Therapy Proves Mettle in High-Risk Prostate Cancerѻýҕl> Hypofractionation matches standard RT for survival and toxicity in a third less time Oct 25, 2022
<ѻýҕl>Low Rates of PSA Screening Linked to Increase in Metastatic Prostate Cancerѻýҕl> Will USPSTF's 2018 guidelines reverse this trend? Oct 25, 2022
<ѻýҕl>New Standard-of-Care Therapy for Advanced Liver Cancerѻýҕl> Stereotactic body radiotherapy plus sorafenib improves survival versus targeted drug alone Oct 24, 2022
<ѻýҕl>Nerve-Freezing Technique Staves Off Post-Mastectomy Painѻýҕl> Percutaneous cryoneurolysis improved analgesia in a pilot study Oct 24, 2022
<ѻýҕl>Rapid Radiotherapy Technique Shows Promise in First Human Trialѻýҕl> FLASH relieved pain in most patients with bone metastases, with few side effects Oct 24, 2022
<ѻýҕl>High-Dose-Rate Brachytherapy Boost in Prostate Cancer Improves QOLѻýҕl> Patients report better urinary and bowel function outcomes Oct 24, 2022
<ѻýҕl>FDA Approves New CTLA-4 Inhibitor for Cancer Treatmentѻýҕl> Tremelimumab (Imjudo), in combination with durvalumab, lands approval in advanced liver cancer Oct 24, 2022
<ѻýҕl>Is Your Oven Leaking Cancer-Causing Chemicals Into Your Kitchen?ѻýҕl> Study finds that natural gas leaks result in elevated benzene levels, even when stove not in use Oct 20, 2022
<ѻýҕl>Should We Still Be Concerned About Cell Phones and Brain Cancer?ѻýҕl> Experts weigh in on why the topic has seemed to lose steam in recent years Oct 20, 2022
<ѻýҕl>Mepitel Film Beats Standard for Stopping Radiation Dermatitis in Breast Cancerѻýҕl> "The most improvement in skin toxicity that I have seen in many years," expert says Oct 19, 2022
<ѻýҕl>Risk of Secondary Breast Cancer After Childhood Cancer Is Declining, Study Suggestsѻýҕl> Improvement credited to changes in chest RT, attenuated by use of pelvic RT, anthracyclines Oct 13, 2022
<ѻýҕl>This One Risk Factor Dominates for Soft Tissue Sarcoma After Breast Cancerѻýҕl> Risk is low but appears to have modifiable components Oct 13, 2022
<ѻýҕl>U.S. Experts Weigh In on Colonoscopy Status in Wake of European Trialѻýҕl> Concerns abound after study suggests colonoscopy may be less effective than expected Oct 12, 2022
<ѻýҕl>Caregiving at the Endѻýҕl> Co-host Tyler Johnson talks with the husband of previous guest, Ellen Dunphy, who died in July Oct 11, 2022 podcast
<ѻýҕl>Lung Cancer Screening Programs Hit the Mark on Eligibility Criteriaѻýҕl> However, adherence to follow-up screening is "suboptimal" Oct 10, 2022
<ѻýҕl>More Evidence Backing Anti-CDK4/6-Based Therapy in Recurrent Endometrial Cancerѻýҕl> Abemaciclib plus letrozole led to 30% objective response rate, 55.6% PFS rate at 6 months Oct 10, 2022
<ѻýҕl>If You Invite 455 People to Colonoscopy, You'll Stop One Case of Cancerѻýҕl> Risk of colorectal cancer reduced with screening in randomized trial, but less than expected Oct 09, 2022
<ѻýҕl>Katie Couric's Breast Cancerѻýҕl> The popular media personality is on a mission to raise awareness around dense breasts Oct 06, 2022
<ѻýҕl>FDA's Power Morcellator Warning Tied to Drop in Distant Leiomyosarcomasѻýҕl> Local and regional illness remained unchanged Oct 04, 2022
<ѻýҕl>Combo Therapy Shows Promise in Advanced Thymic Epithelial Tumorsѻýҕl> "Clinically remarkable outcomes" with PD-L1 inhibitor plus anti-angiogenesis agent Oct 04, 2022
<ѻýҕl>Pandemic Led to Surgical Delays in Gynecologic Cancers, and Worse Outcomesѻýҕl> One in five patients experienced changes in their care plan Oct 04, 2022
<ѻýҕl>SABR for Oligometastatic Cancer Turns in 'Acceptable' Rates of Toxicityѻýҕl> Rates of grade 2 or higher toxicities less than those observed in landmark SABR-COMET study Oct 03, 2022
<ѻýҕl>Adding Chemo Not Better for Recurrent Endometrial Cancerѻýҕl> Trial suggests radiation therapy alone remains standard of care for pelvic-only recurrences Oct 03, 2022
<ѻýҕl>Transplant With Orca-T Reduced GVHD in Hematologic Malignanciesѻýҕl> Risk of relapse was also lower in the group who received the cell therapy Oct 03, 2022
<ѻýҕl>Durvalumab-CRT Pairing Disappoints in Locally Advanced Cervical Cancerѻýҕl> Still, CALLA trial findings "will inform future strategies to improve treatment," researcher says Oct 02, 2022
<ѻýҕl>ADC Offers Promising Results in Relapsed or Refractory Hodgkin Lymphomaѻýҕl> Good response rate with camidanlumab tesirine, although a lot of patients experienced AEs Oct 02, 2022
<ѻýҕl>Rucaparib a Winner for PFS, But Not for OS, in Recurrent Ovarian Cancerѻýҕl> PARP inhibitor still has value as maintenance therapy, ARIEL3 investigator says Oct 01, 2022
<ѻýҕl>'Potential Detrimental Effect' With Fourth-Line Olaparib in Ovarian Cancerѻýҕl> Post-hoc data from SOLO3 show diverging results based on prior lines of therapy Sep 30, 2022
<ѻýҕl>Anti-BCMA-Based Regimen Impresses in Relapsed/Refractory Myelomaѻýҕl> Belamaf plus lenalidomide-dexamethasone achieved encouraging responses Sep 30, 2022
<ѻýҕl>Response-Based Ponatinib Dose Reduction a Win-Win in Chronic-Phase CML?ѻýҕl> Strategy applied in OPTIC trial may mitigate adverse events without sacrificing benefit Sep 29, 2022
<ѻýҕl>Magrolimab-Azacitidine Shows Promise in Untreated High-Risk MDSѻýҕl> About a third of patients, including those with TP53 mutations, achieved complete remission Sep 29, 2022
<ѻýҕl>Immunotherapy First for BRAF Melanoma Edges Out Targeted Combinationѻýҕl> "Clinically meaningful" improvement in 2- and 3-year survival Sep 28, 2022
<ѻýҕl>Was I Conned by a 'Grey's Anatomy' Writer?ѻýҕl> Her alleged duplicity could make things tougher for female patients Sep 27, 2022
<ѻýҕl>Cancer in Kids Tied to Prenatal Exposure to High-Dose Folic Acid and Seizure Medsѻýҕl> But no link seen among children of mothers without epilepsy Sep 26, 2022
<ѻýҕl>'Unparalleled Times' in Hematology, but Workforce Issues Persistѻýҕl> "This is the most exciting time ever" to be a hematologist, says ASH President Jane Winter, MD Sep 26, 2022 video
<ѻýҕl>What's on Tap at the Society of Hematologic Oncology's 10th Annual Meetingѻýҕl> Emphasis on novel biological approaches in treating patients with hematologic malignancies Sep 26, 2022
<ѻýҕl>FDA Grants First Tumor-Agnostic Approval for RET Fusion-Positive Cancersѻýҕl> Selpercatinib approved for advanced or metastatic solid tumors that progress on systemic therapy Sep 22, 2022
<ѻýҕl>How Does Oncology Deal With Pandemic Burnout?ѻýҕl> Evidence suggests the pandemic could have long-term consequences Sep 20, 2022